ReviewWorld journal of hepatology2021

Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice.

Ankit Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.